
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Teprotumumab Divergently Alters Fibrocyte Gene Expression: Implications for Thyroid-associated Ophthalmopathy - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="939BE807DB0F4BC50000395FD897C89C.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="jcem" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC9516078/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516078/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="The Journal of Clinical Endocrinology and Metabolism" /><meta name="citation_title" content="Teprotumumab Divergently Alters Fibrocyte Gene Expression: Implications for Thyroid-associated Ophthalmopathy" /><meta name="citation_author" content="Roshini Fernando" /><meta name="citation_author_institution" content="Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, Ann Arbor, MI 48105, USA" /><meta name="citation_author_institution" content="Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105, USA" /><meta name="citation_author" content="Terry J Smith" /><meta name="citation_author_institution" content="Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, Ann Arbor, MI 48105, USA" /><meta name="citation_author_institution" content="Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105, USA" /><meta name="citation_publication_date" content="2022/10" /><meta name="citation_issue" content="10" /><meta name="citation_volume" content="107" /><meta name="citation_firstpage" content="e4037" /><meta name="citation_doi" content="10.1210/clinem/dgac415" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC9516078/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC9516078/" /><meta name="citation_pmid" content="35809263" /><meta name="DC.Title" content="Teprotumumab Divergently Alters Fibrocyte Gene Expression: Implications for Thyroid-associated Ophthalmopathy" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="The Endocrine Society" /><meta name="DC.Contributor" content="Roshini Fernando" /><meta name="DC.Contributor" content="Terry J Smith" /><meta name="DC.Date" content="2022 Oct" /><meta name="DC.Identifier" content="10.1210/clinem/dgac415" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Teprotumumab Divergently Alters Fibrocyte Gene Expression: Implications for Thyroid-associated Ophthalmopathy" /><meta property="og:type" content="article" /><meta property="og:description" content="Teprotumumab, an IGF-I receptor (IGF-IR) inhibitor, is effective in thyroid-associated ophthalmopathy (TAO). The drug can modulate induction by TSH of IL-6 and IL-8 in CD34[+&#x02005;] fibrocytes and their putative derivatives, CD34[+&#x02005;] orbital ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516078/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9516078/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22J Clin Endocrinol Metab%22[journal]" class="navlink">J Clin Endocrinol Metab</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC9516078
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="other_item"><a href="/pmc/articles/PMC9516078/?report=printable" class="sidefm-pmclink">Printer Friendly</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/9516078/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/9516078/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="9516078" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9516078%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="HzCe3FVMaZuQE1gdys2jTqkj7pzbhChNs1pyLnbH5mIHc44G6E7vZmxlGRXBtcIw">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9516078%2F&amp;text=Teprotumumab%20Divergently%20Alters%20Fibrocyte%20Gene%20Expression%3A%20Implications%20for%20Thyroid-associated%20Ophthalmopathy" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9516078%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516078/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC9516078/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/35809263/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC9516078/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/35809263/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC9516078/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/9516078/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22J Clin Endocrinol Metab%22[journal]" class="navlink">J Clin Endocrinol Metab</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC9516078
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-jcem.jpg" alt="Logo of jcem" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://academic.oup.com/jcem/" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">J Clin Endocrinol Metab.</span> 2022 Oct; 107(10): e4037–e4047. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2022 Jul 9. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1210%2Fclinem%2Fdgac415" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1210/clinem/dgac415</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC9516078</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35809263">35809263</a></div></div></div><h1 class="content-title">Teprotumumab Divergently Alters Fibrocyte Gene Expression: Implications for Thyroid-associated Ophthalmopathy</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Fernando%20R%5BAuthor%5D" class="affpopup" co-rid="_co_idm139757112492640" co-class="co-affbox">Roshini Fernando</a> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Smith%20TJ%5BAuthor%5D" class="affpopup" co-rid="_co_idm139757117206864" co-class="co-affbox">Terry J Smith</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139757112492640"><h3 class="no_margin">Roshini Fernando</h3><p>
Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, Ann Arbor, MI 48105, USA</p><p>
Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Fernando%20R%5BAuthor%5D">Roshini Fernando</a></div></div><div id="_co_idm139757117206864"><h3 class="no_margin">Terry J Smith</h3><p>
Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, Ann Arbor, MI 48105, USA</p><p>
Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105, USA</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Smith%20TJ%5BAuthor%5D">Terry J Smith</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm139757122419712_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139757122419712_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139757122419712_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm139757122419712_ai" style="display:none"><div><span class="fm-affl">Roshini Fernando, </span><span class="fm-affl" id="aff-a.i.b.f.a.b"> 
Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, Ann Arbor, MI 48105, USA;</span><span class="fm-affl" id="aff-a.i.b.f.a.c"> 
Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105, USA;</span></div><div><a href="#article-aaff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div id="c1">Correspondence: Terry J. Smith, MD, Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, Brehm Tower, 1000 Wall St, Ann Arbor, MI 48105, USA. Email: <a href="mailto:dev@null" data-email="ude.hcimu.dem@imsyrret" class="oemail">ude.hcimu.dem@imsyrret</a></div></div><div class="fm-article-notes hide half_rhythm" id="idm139757122419712_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2022 Apr 11</div></div><div class="permissions half_rhythm hide" id="idm139757122419712_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com</div><div class="license half_rhythm">This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<a href="https://academic.oup.com/pages/standard-publication-reuse-rights" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">https://academic.oup.com/pages/standard-publication-reuse-rights</a>)</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-length="143" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p class="p p-first-last">Original data generated and analyzed during this study are included in this published article or in the data repositories listed in References.</p></dd></dl></div><div id="abstract-a.i.b.r" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.i.b.rtitle">Abstract</h2><!--article-meta--><div><div id="s1" class="sec sec-first"><h3 id="s1title">Context</h3><p class="p p-first-last">Teprotumumab, an IGF-I receptor (IGF-IR) inhibitor, is effective in thyroid-associated ophthalmopathy (TAO). The drug can modulate induction by TSH of IL-6 and IL-8 in CD34<sup>+&#x02005;</sup>fibrocytes and their putative derivatives, CD34<sup>+&#x02005;</sup>orbital fibroblasts (CD34<sup>+&#x02005;</sup>OF). Fibrocytes express multiple thyroid autoantigens and cytokines implicated in TAO, which are downregulated by Slit2. Inflammation and disordered hyaluronan (HA) accumulation occur in TAO. Whether teprotumumab alters these processes directly in fibrocytes/CD34<sup>+&#x02005;</sup>OF remains uncertain.</p></div><div id="s2" class="sec"><h3 id="s2title">Objective</h3><p class="p p-first-last">Determine teprotumumab effects on expression/synthesis of several TAO-relevant molecules in fibrocytes and GD-OF.</p></div><div id="s3" class="sec"><h3 id="s3title">Design/Setting/Participants</h3><p class="p p-first-last">Patients with TAO and healthy donors were recruited from an academic endocrine and oculoplastic practice.</p></div><div id="s4" class="sec"><h3 id="s4title">Main outcome measures</h3><p class="p p-first-last">Real-time PCR, specific immunoassays.</p></div><div id="s5" class="sec"><h3 id="s5title">Results</h3><p class="p p-first-last">Teprotumumab attenuates basal and TSH-inducible autoimmune regulator protein, thyroglobulin, sodium iodide symporter, thyroperoxidase, IL-10, and B-cell activating factor levels in fibrocytes. It downregulates IL-23p19 expression/induction while enhancing IL-12p35, intracellular and secreted IL-1 receptor antagonists, and Slit2. These effects are mirrored by linsitinib. HA production is marginally enhanced by teprotumumab, the consequence of enhanced HAS2 expression.</p></div><div id="s6" class="sec sec-last"><h3 id="s6title">Conclusion</h3><p class="p p-first-last">Teprotumumab affects specific gene expression in fibrocytes and GD-OF in a target-specific, nonmonolithic manner, whereas IGF-IR control of these cells appears complex. The current results suggest that the drug may act on cytokine expression and HA production systemically and locally, within the TAO orbit. These findings extend our insights into the mechanisms through which IGF-IR inhibition might elicit clinical responses in TAO, including a potential role of Slit2 in attenuating inflammation and tissue remodeling.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Graves&#x02019; disease, orbit, fibroblasts, cytokine, ophthalmopathy, hyaluronan</span></div></div><div id="body-a.j" class="tsec sec"><h2 class="headless nomenu"></h2><p class="p p-first">Thyroid-associated ophthalmopathy (TAO), an autoimmune component of fully expressed Graves&#x02019; disease (GD), remains a vexing, disfiguring, and potentially sight-threatening disorder (<a href="#CIT0001" rid="CIT0001" class=" bibr popnode">1</a>). Historically, management of TAO has remained suboptimal, resulting from an absence of safe and effective medications. The disease involves anatomic-site-selective activation of orbital and upper facial tissues, which become inflamed, congested, and remodeled. The central, disease-specific autoantigen in GD, TSH receptor (TSHR), is targeted by thyroid-stimulating immunoglobulin (TSI), frequently resulting in thyroid dysfunction (<a href="#CIT0002" rid="CIT0002" class=" bibr popnode">2</a>). Evidence for TSHR playing important roles in TAO rests largely on its expression in orbital connective tissue (<a href="#CIT0003" rid="CIT0003" class=" bibr popnode">3</a>) and orbital fibroblasts (GD-OF) (<a href="#CIT0004" rid="CIT0004" class=" bibr popnode">4</a>). GD-OF respond robustly to TSH and TSI in vitro (<a href="#CIT0005" rid="CIT0005" class=" bibr popnode">5-7</a>). Further, circulating TSI levels broadly correlate with the clinical behavior of TAO (<a href="#CIT0008" rid="CIT0008" class=" bibr popnode">8</a>, <a href="#CIT0009" rid="CIT0009" class=" bibr popnode">9</a>). Activity of another, more recently identified pathogenic component of TAO, the IGF-I receptor (IGF-IR), is required for many actions of TSH and TSI (<a href="#CIT0010" rid="CIT0010" class=" bibr popnode">10</a>). Patients with GD and TAO appear to generate autoantibodies against IGF-IR (<a href="#CIT0011" rid="CIT0011" class=" bibr popnode">11</a>, <a href="#CIT0012" rid="CIT0012" class=" bibr popnode">12</a>); however, whether these autoantibodies might directly and independently initiate signaling remains a topic of considerable debate (<a href="#CIT0013" rid="CIT0013" class=" bibr popnode">13</a>). Confirmation that IGF-IR plays a critical role in TAO was provided by dramatic and unprecedented clinical responses to teprotumumab, a highly specific IGF-IR inhibitor, observed in 2 therapeutic trials (<a href="#CIT0014" rid="CIT0014" class=" bibr popnode">14</a>, <a href="#CIT0015" rid="CIT0015" class=" bibr popnode">15</a>). The drug reduces proptosis and inflammation and improves diplopia in active, moderate, to severe TAO. Results from those trials led to the recent US Food and Drug Administration approval of teprotumumab for TAO (<a href="#CIT0016" rid="CIT0016" class=" bibr popnode">16</a>). Importantly, the mechanism(s) underlying the effectiveness of teprotumumab has yet to be fully characterized. We have very recently reported that the monoclonal antibody alters the immune phenotype of fibrocytes, both in vitro and in vivo, suggesting that systemic actions may be involved (<a href="#CIT0017" rid="CIT0017" class=" bibr popnode">17</a>).</p><p>Among hallmarks of tissue remodeling associated with TAO are elevated expression levels of specific cytokines, inflammation, and abnormal accumulation of hyaluronan (HA) in the orbit and upper face (<a href="#CIT0018" rid="CIT0018" class=" bibr popnode">18</a>). This pathology results from increased activities of GD-OF, heterogeneous cells that differ markedly from orbital fibroblasts found in healthy individuals (<a href="#CIT0006" rid="CIT0006" class=" bibr popnode">6</a>, <a href="#CIT0019" rid="CIT0019" class=" bibr popnode">19</a>, <a href="#CIT0020" rid="CIT0020" class=" bibr popnode">20</a>). Relatively recent insights have identified the presence of CD34<sup>+&#x02005;</sup>CXCR4<sup>+&#x02005;</sup>Collagen I<sup>+&#x02005;</sup>TSHR<sup>bright</sup> cells among GD-OF (<a href="#CIT0006" rid="CIT0006" class=" bibr popnode">6</a>, <a href="#CIT0021" rid="CIT0021" class=" bibr popnode">21</a>). These fibroblasts are currently thought to represent derivatives of bone marrow-derived CD34<sup>+&#x02005;</sup>fibrocytes. Fibrocytes represent myeloid precursors of the monocyte lineage that actively participate in wound healing and scar formation (<a href="#CIT0022" rid="CIT0022" class=" bibr popnode">22</a>). They synthesize several proteins, the expression of which was thought historically to be limited to the thyroid gland (<a href="#CIT0023" rid="CIT0023" class=" bibr popnode">23</a>,<a href="#CIT0024" rid="CIT0024" class=" bibr popnode">24</a>). TSHR/IGF-IR interactions occurring in fibrocytes and GD-OF lead to cell activation and enhanced biosynthetic phenotypes (<a href="#CIT0005" rid="CIT0005" class=" bibr popnode">5</a>, <a href="#CIT0010" rid="CIT0010" class=" bibr popnode">10-12</a>). We have demonstrated recently the dramatically divergent capacity of fibrocytes and GD-OF to generate HA (<a href="#CIT0025" rid="CIT0025" class=" bibr popnode">25</a>). Although GD-OF generate copious amounts of HA, fibrocytes synthesize relatively little. These differences result from a cell-type specific pattern of hyaluronan synthase (HAS) isoenzyme and UDP-glucose dehydrogenase expression (<a href="#CIT0025" rid="CIT0025" class=" bibr popnode">25-28</a>).</p><p class="p">Earlier reports from our group demonstrated that TSH-dependent IL-6 and IL-8 expression in fibrocytes is substantially downregulated by teprotumumab in vitro (<a href="#CIT0029" rid="CIT0029" class=" bibr popnode">29</a>). The current studies were undertaken to explore further the effects of this drug on fibrocytes and GD-OF and whether these effects could be implicated in the therapeutic impact of teprotumumab in TAO. They were also designed to allow comparisons between the actions of teprotumumab and Slit2, a neural axon guidance glycoprotein that can attenuate the expression of several fibrocyte proteins implicated in TAO (<a href="#CIT0017" rid="CIT0017" class=" bibr popnode">17</a>, <a href="#CIT0030" rid="CIT0030" class=" bibr popnode">30-32</a>). We have proposed that Slit2, by its actions mediated through roundabout 1 (ROBO1), its cognate receptor, may represent a key endogenous determent of TAO activity and severity (<a href="#CIT0030" rid="CIT0030" class=" bibr popnode">30</a>). Here, we demonstrate that teprotumumab inhibits the expression and in some cases, induction by bovine TSH (bTSH) of several &#x0201c;thyroid-specific&#x0201d; proteins, including TSHR, thyroglobulin (Tg), thyroperoxidase (TPO), and sodium-iodide symporter (NIS). In addition, basal expression and bTSH induction of autoimmune regulator protein (AIRE), HAS1, B cell-activating factor (BAFF), soluble IL-1 receptor antagonist (sIL-1RA), IL-23, and IL-10 in both cell types are attenuated either partially or completely by teprotumumab. In contrast, the monoclonal antibody enhances IL-12p35, intracellular IL-1RA (icIL-1RA), and HAS2 expression. Thus, it would appear that several potentially important therapeutic responses to IGF-IR inhibition might be mediated, at least in part, through direct effects on these cells. In contrast, HA synthesis by GD-OF is not inhibited directly and may be somewhat increased by teprotumumab, suggesting that an intermediate cell type(s) may be involved in these effects <em>in vivo.</em></p></div><div id="s7" class="tsec sec"><h2 class="head no_bottom_margin" id="s7title">Materials and Methods</h2><div id="s8" class="sec sec-first"><h3 id="s8title">Materials</h3><p class="p p-first-last">DMEM (cat. #11965) containing 4.5 g/mL D-glucose and L-glutamine, penicillin-streptomycin mixture (cat. #15140), and fetal bovine serum (FBS) (cat. #16000-044) were purchased from Life Technologies (Grand Island, NY). Bovine TSH (cat. #T1614) was from Scripps Laboratories, San Diego, CA. Human CD34<sup>+&#x02005;</sup>nucleofection kit (cat. #VPA-1003) was supplied by Lonza, Allendale, NJ. An HA ELISA kit (K-1200, RRID:<a href="https://scicrunch.org/resolver/AB_2916099" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">AB_2916099</a>) was purchased from Echelon Biosciences Inc. (Salt Lake City, UT). ELISAs for human BAFF (cat. #DBLYSOB, RRID:<a href="https://scicrunch.org/resolver/AB_2916100" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">AB_2916100</a>), IL-10 (cat. #D1000B, RRID:<a href="https://scicrunch.org/resolver/AB_2916101" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">AB_2916101</a>), human IL-12 (cat. #D1200, RID:AB_2916102), human IL-23 (cat. #D2300B, RRID:<a href="https://scicrunch.org/resolver/AB_2916103" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">AB_2916103</a>), and sIL-1RA (cat.#DRA00B, RRID:<a href="https://scicrunch.org/resolver/AB_2916104" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">AB_2916104</a>) were from R &#x00026; D Systems, Minneapolis, MN. Slit2 (cat. #ab100637, RRID:<a href="https://scicrunch.org/resolver/AB_2916105" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">AB_2916105</a>) and icIL-1RA (ab211650, RRID:<a href="https://scicrunch.org/resolver/AB_10846099" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">AB_10846099</a>?) were from Bio-Rad, Hercules, CA. and PE mouse anti-human CD34 (cat. #555822, RRID:<a href="https://scicrunch.org/resolver/AB_396151" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">AB_396151</a>) and mouse IgG1 isotype control-PE (cat. #555749, RRID:<a href="https://scicrunch.org/resolver/AB_396091" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">AB_396091</a>) came from BD Biosciences, San Diego, CA. Accutase (cat. #SCR005) was from Millipore, Billerica, MA. Teprotumumab (RRID:<a href="https://scicrunch.org/resolver/AB_2911058" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">AB_2911058</a>) was kindly provided by River Vision and Horizon Therapeutics.</p></div><div id="s9" class="sec sec-last"><h3 id="s9title">Methods</h3><div id="s10" class="sec sec-first"><h4 id="s10title">Research participant recruitment</h4><p class="p p-first-last">A total of 40 individuals with stable TAO and 10 healthy control subjects were recruited from academic endocrine and oculoplastic practices at the University of Michigan Health System providing peripheral blood mononuclear cells (PBMCs). Patients undergoing surgical orbit decompressions with stable, severe TAO (n&#x02005;=&#x02005;4) provided strains of GD-OF comprising CD34<sup>+&#x02005;</sup>OF and CD34<sup>&#x02013;</sup> OF, as reported previously (<a href="#CIT0023" rid="CIT0023" class=" bibr popnode">23</a>). Verbal and written informed consent was obtained from all subjects before their study participation. These activities have been approved by the University of Michigan institutional review board. Additional blood samples were supplied by the American Red Cross.</p></div><div id="s11" class="sec"><h4 id="s11title">Fibrocyte and GD-OF cultivation</h4><p class="p p-first">Fibrocytes were prepared as described by Bucala et al (<a href="#CIT0022" rid="CIT0022" class=" bibr popnode">22</a>) with slight modification (<a href="#CIT0006" rid="CIT0006" class=" bibr popnode">6</a>) in that they are not routinely cultivated on fibronectin-coated substratum. PBMCs were isolated by Ficoll Histopaque (Sigma-Aldrich, St. Louis, MO) density gradient centrifugation. Six-well plates were inoculated with 10<sup>7</sup> PBMCs and covered with DMEM containing 10% FBS and penicillin/streptomycin. After 10 to 12 days in culture, adherent monolayers (&#x0003c;5% of the starting population) were rinsed and removed from substratum by mechanical scraping following Accutase treatment. Culture purity was confirmed routinely by FACS analysis to be &#x0003e;90% fibrocytes based on their consistent CD31<sup>&#x02013;</sup>CD45<sup>+&#x02005;</sup>CD34<sup>+&#x02005;</sup>CXCR4<sup>+&#x02005;</sup>Col I<sup>+&#x02005;</sup>TSHR<sup>high</sup> phenotype.</p><p class="p p-last">GD-OF were cultivated from deep fat removed during surgical orbital decompression as described (<a href="#CIT0020" rid="CIT0020" class=" bibr popnode">20</a>, <a href="#CIT0033" rid="CIT0033" class=" bibr popnode">33</a>). The fraction of CD34<sup>+&#x02005;</sup>OF in GD-OF strains varies somewhat but usually approximates 50%. Early passages used in these studies ranged from 2 to 8, an interval during which the cells exhibited a stable phenotype (<a href="#CIT0034" rid="CIT0034" class=" bibr popnode">34</a>). In those studies examining pure CD34<sup>+&#x02005;</sup>and CD34<sup>&#x02013;</sup> subsets, GD-OF were subjected to cytometric cell sorting using a FACSAria III (BD Biosciences) instrument. Cell monolayers were stained for 30 minutes at 4&#x000b0;C with fluorescein isothiocyanate-conjugated anti-mouse CD34 or its isotype control. Rinsed cells were sorted under sterile conditions into CD34<sup>+&#x02005;</sup>OF and CD34<sup>&#x02013;</sup> OF subsets. These were then recultured for 48 to 72 hours and treated as indicated in the figure legends without or with bTSH (5 mU/mL) for 6 hours alone or with a test compound.</p></div><div id="s12" class="sec"><h4 id="s12title">RNA preparation and real-time PCR</h4><p class="p p-first">GD-OF strains were inoculated into 6-well plates in 10% FBS-supplemented DMEM. Confluent cultures were shifted to DMEM without or with bTSH (5 mIU/mL), teprotumumab (50 &#x000b5;g/mL) or linsitinib (1 &#x000b5;M) was added as single agents or the combinations and time intervals indicated. Cellular RNA was extracted with an Aurum TM Total RNA Mini Kit (Bio-RAD, Hercules, CA, cat. #732-6820). RNA (2 &#x000b5;g) was reverse-transcribed and real-time PCR was performed using an Applied Biosystems instrument and QuantiTect SybrGreen PCR kits (Qiagen, cat #204143). Primer sequences synthesized by Life Technologies were as follows: GAPDH forward, 5&#x02032;-TTGCCATCAATGACCCCTTCA-3&#x02032;, reverse, 5&#x02032;-GCCC-CACTTGATTTTGGA; HAS1, CGATACTGGGTAGCCTTCAATG-3&#x02032;, reverse, 5&#x02032;-GGAGGTGTACTTGGTAGCATAA CC-3; HAS2, forward, 5&#x02032;- GTGTTATACATGTC-GAGTTTACTTCC -3&#x02032;&#x02019; reverse, 5&#x02032;- GTC- ATATTGTTGTCCCTTCTTCCGC-3&#x02032;; BAFF forward, 5&#x02032;-GAGAAGCTGCCAGCAGGA-3; reverse, 5&#x02032;-TCCTGGAGCTGGTGGTTC-3&#x02032;. Quantitect primer assays were from Qiagen (Frederick, MD). Sample values were generated against a standard curve and normalized to GAPDH signals.</p><p class="p p-last">
<em>IL-12, IL-23, IL-10, HA, and BAFF ELISAs.</em> Confluent cultures were treated with nothing or teprotumumab (50 &#x000b5;g/mL) for 5 days, without or with bTSH (5 mU/mL) for the intervals indicated or 72 hours. Media and rinsed cell layers were homogenized in 0.1M NaCl and assayed for HA content using an ELISA kit (K-1200) from Echelon Biosciences Inc. (Salt Lake City, UT) according to the manufacturer&#x02019;s instructions. A BAFF-specific ELISA, purchased from R &#x00026; D Systems, was used in accordance with the manufacturer&#x02019;s instructions.</p></div><div id="s13" class="sec sec-last"><h4 id="s13title">Statistics</h4><p class="p p-first-last">Statistical significance was determined by a 2-tailed Student <em>t</em> test. Analyses were performed with SAS version 9.4 (Cary, NC).</p></div></div></div><div id="s14" class="tsec sec"><h2 class="head no_bottom_margin" id="s14title">Results</h2><div id="s15" class="sec sec-first"><h3 id="s15title">Effects of Teprotumumab on Thyroid Autoantigen Expression in Fibrocytes</h3><p class="p p-first">Fibrocytes express relatively high levels of functional TSHR (<a href="#CIT0006" rid="CIT0006" class=" bibr popnode">6</a>), Tg, NIS, and TPO (<a href="#CIT0023" rid="CIT0023" class=" bibr popnode">23</a>, <a href="#CIT0024" rid="CIT0024" class=" bibr popnode">24</a>). Expression of those proteins is dependent on the AIRE protein, which in fibrocytes is inducible by bTSH (<a href="#CIT0024" rid="CIT0024" class=" bibr popnode">24</a>). Further, Slit2, a neural axon repellent generated by CD34<sup>&#x02013;</sup> OF, attenuates the expression of these proteins (<a href="#CIT0030" rid="CIT0030" class=" bibr popnode">30</a>). Here, we find that teprotumumab (50 &#x003bc;g/mL) for 7 to 9 days inhibits the basal expression and induction by bTSH (5 mIU/mL for 6 hours) of AIRE (<a href="/pmc/articles/PMC9516078/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1A</span></a>), Tg (<a href="/pmc/articles/PMC9516078/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1B</span></a>), TPO (<a href="/pmc/articles/PMC9516078/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1C</span></a>), and NIS (<a href="/pmc/articles/PMC9516078/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1D</span></a>) in cultured fibrocytes compared with an isotype control monoclonal antibody. The extent of inhibition, both regarding basal expression of the transcripts and the induction by bTSH, varies among the targets. In some cases, the effects of teprotumumab may result from its inhibition mainly of bTSH-independent mRNA levels.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC9516078/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139757111362112"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9516078_dgac415f0001.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is dgac415f0001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9516078/bin/dgac415f0001.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139757111362112"><a target="object" rel="noopener" href="/pmc/articles/PMC9516078/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC9516078/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1.</a></div><!--caption a7--><div class="caption"><p>Effect of teprotumumab on bTSH-induced thyroid-specific genes Tg, TPO, NIS, and AIRE in fibrocytes. Confluent fibrocyte cultures were treated with or without teprotumumab (50 &#x000b5;g/mL) or human isotype IgG for 7-9 days, followed by bTSH (5 mIU/mL) for 6 hours. Monolayers were washed with PBS and RNA was extracted and reverse transcribed. Harvested cDNA was subjected to quantitative real-time PCR for (A) AIRE, (B) Tg, (C) TPO, and (D) NIS mRNA levels. Values were normalized to their respective GAPDH levels and are expressed as the mean&#x02005;&#x000b1;&#x02005;SD of 3 independent determinations. Experiments were repeated 3 times. *<em>P</em>&#x02005;&#x0003c;&#x02005;0.05; **<em>P</em>&#x02005;&#x0003c;&#x02005;0.01.</p></div></div></div></div><div id="s16" class="sec"><h3 id="s16title">Teprotumumab Attenuates IL-23p19 Expression While Enhancing That of IL-12p35</h3><p class="p p-first">IL-12 and IL-23 are 2 key cytokines determining immune responses, in part through the polarization and expansion of T cells to the Th1 and Th17 phenotypes, respectively (<a href="#CIT0035" rid="CIT0035" class=" bibr popnode">35</a>). They are differentially expressed in fibrocytes and GD-OF, apparently the consequence of divergent actions of endogenously expressed Slit2 in the CD34<sup>&#x02013;</sup> OF subset (<a href="#CIT0031" rid="CIT0031" class=" bibr popnode">31</a>). In GD-OF, the down-regulatory effects of CD34<sup>&#x02013;</sup> OF have been shown to be the consequence, at least in part, of Slit2. Here, we find that teprotumumab inhibits basal IL-23p19 expression and induction by bTSH in both fibrocytes (<a href="/pmc/articles/PMC9516078/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2A</span></a>) and GD-OF (<a href="/pmc/articles/PMC9516078/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2B</span></a>). In contrast, the IGF-IR inhibitor enhances IL-12p35 expression and induction by bTSH in both cell types. The effects of teprotumumab are dose-dependent (Supplemental Fig. 1) (<a href="#CIT0025" rid="CIT0025" class=" bibr popnode">25</a>). Impact of linsitinib (1 &#x000b5;M), a small molecule IGF-IR inhibitor, is congruent with that of teprotumumab, and similarly discordant with regard to IL-23p19 and IL-12p35 in these cell types (<a href="/pmc/articles/PMC9516078/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2C</span></a> and <a href="/pmc/articles/PMC9516078/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and2D).</span></span><span>2D</span></a>). These findings suggest that IGF-IR may play an important role in maintaining the balance between IL-23 and IL-12 generation in both fibrocytes and GD-OF, effects that resemble those of the Slit2/ROBO1 pathway (<a href="#CIT0031" rid="CIT0031" class=" bibr popnode">31</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC9516078/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139757112174864"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9516078_dgac415f0002.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is dgac415f0002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9516078/bin/dgac415f0002.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139757112174864"><a target="object" rel="noopener" href="/pmc/articles/PMC9516078/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC9516078/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2.</a></div><!--caption a7--><div class="caption"><p>Divergent effect of teprotumumab on bTSH induced IL-23p19 and IL-12p35 expression on fibrocyte and GD-OF. Rinsed fibrocyte and GD-OF monolayers were incubated with or without (A,B) teprotumumab (50 &#x000b5;g/mL) or (C,D) linsitinib (1 &#x000b5;M) and human isotype IgG for 7-9 days, and bTSH (5 mIU/mL) was added for 6 hours. Harvested RNA was reverse transcribed and isolated cDNA was subjected to quantitative real-time PCR for IL-23p19 and IL-12p35 mRNA levels. Values were normalized to their respective GAPDH levels and are expressed as the mean&#x02005;&#x000b1;&#x02005;SD of 3 independent determinations. Experiments were repeated 3 times. **<em>P</em>&#x02005;&#x0003c;&#x02005;0.01; ***<em>P</em>&#x02005;&#x0003c;&#x02005;0.001.</p></div></div></div><p class="p">In contrast to IL-12 and IL-23, cytokines generally enhancing immune responses, IL-10 most frequently inhibits inflammation (<a href="#CIT0036" rid="CIT0036" class=" bibr popnode">36</a>). IL-10 attenuates immune responses as a component of the T-cell regulatory mechanism (<a href="#CIT0037" rid="CIT0037" class=" bibr popnode">37</a>). Fibrocytes express IL-10 mRNA, as demonstrated in <a href="/pmc/articles/PMC9516078/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3A</span></a>. bTSH induces IL-10 by 11-fold, whereas both teprotumumab (<a href="/pmc/articles/PMC9516078/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3A</span></a>) and Slit2 (<a href="/pmc/articles/PMC9516078/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3B</span></a>) downregulate both basal and bTSH-provoked expression. In contrast, teprotumumab (<a href="/pmc/articles/PMC9516078/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3C</span></a>) and Slit2 (<a href="/pmc/articles/PMC9516078/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3D</span></a>) upregulate basal and bTSH-dependent icIL-1RA mRNA levels in fibrocytes. The effects of teprotumumab on icIL-1RA protein levels are minimal (<a href="/pmc/articles/PMC9516078/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3E</span></a>), whereas Slit2 attenuates sIL-1RA mRNA expression in fibrocytes (<a href="/pmc/articles/PMC9516078/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3F</span></a>). Teprotumumab upregulates both icIL-1RA (<a href="/pmc/articles/PMC9516078/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3G</span></a>) and sIL-1RA (<a href="/pmc/articles/PMC9516078/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3H</span></a>) protein levels in GD-OF. Thus, the impact of teprotumumab on cytokines known to influence immune responses is not uniform. Some of its actions reduce whereas others enhance levels of modulating cytokines in fibrocytes and GD-OF.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC9516078/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139757118213440"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9516078_dgac415f0003.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is dgac415f0003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9516078/bin/dgac415f0003.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139757118213440"><a target="object" rel="noopener" href="/pmc/articles/PMC9516078/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC9516078/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3.</a></div><!--caption a7--><div class="caption"><p>Teprotumumab attenuates bTSH induced IL-10 while enhancing icIL-1RA and sIL-1RA expression in fibrocytes and GD-OF. Fibrocyte cultures were treated with teprotumumab (50 &#x000b5;g/mL), rhSlit2 (50 ng/mL) or human isotype IgG for 7-9 days, with bTSH (5 mIU/mL) for the final 6 hours. (A-F) RNA was extracted and reverse transcribed. Isolated cDNA was subjected to quantitative real-time PCR for (A,B) IL-10, (C,D) icIL-1RA, (F) siIL-1RA. (E,G,H) Media and cellular proteins were collected and subjected to specific ELISAs for icIL-1RA and sIL-1RA. PCR values were normalized to their respective GAPDH levels. icIL-1RA and sIL-1RA protein levels were normalized to cellular protein levels. Data are expressed as the mean&#x02005;&#x000b1;&#x02005;SD of 3 independent determinations. Experiments were repeated 3 times. **<em>P</em>&#x02005;&#x0003c;&#x02005;0.01; ***<em>P</em>&#x02005;&#x0003c;&#x02005;0.001.</p></div></div></div></div><div id="s17" class="sec"><h3 id="s17title">Teprotumumab Inhibits Basal BAFF Expression and Induction by bTSH</h3><p class="p p-first">BAFF and its pathway exert an important influence on B-cell survival (<a href="#CIT0038" rid="CIT0038" class=" bibr popnode">38</a>, <a href="#CIT0039" rid="CIT0039" class=" bibr popnode">39</a>). Since its discovery, BAFF has been the focus of developmental therapeutic targeting of autoreactive B cells. Because autoantibody generation appears integral to GD and TAO, we determined whether fibrocytes and GD-OF generate BAFF. Constitutive BAFF mRNA levels are manifold higher in fibrocytes than in GD-OF (<a href="/pmc/articles/PMC9516078/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4A</span></a>). The transcript is time-dependently induced by bTSH in both cell types, peaking at 12 hours and then declining. By 96 hours, levels in fibrocytes have returned to baseline, whereas those in GD-OF remain elevated. BAFF protein levels are similarly induced in fibrocytes, peaking at 24 hours and returning to baseline levels by 72 hours (<a href="/pmc/articles/PMC9516078/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4B</span></a>). A comparison of the basal and bTSH-dependent expression of BAFF mRNA (treated for 12 hours), in multiple strains of fibrocytes and GD-OF demonstrates a consistent pattern, although absolute levels of the transcript vary among the strains (<a href="/pmc/articles/PMC9516078/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4C</span></a>). Teprotumumab partially attenuates bTSH induction of BAFF in fibrocytes (<a href="/pmc/articles/PMC9516078/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4D</span></a>), compared with a more complete inhibition by Slit2 (<a href="/pmc/articles/PMC9516078/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4E</span></a>). To determine whether the relatively low BAFF expression levels in GD-OF compared with fibrocytes were the consequence of factors from CD34<sup>&#x02013;</sup> OF, parental strains of GD-OF containing a mixture of CD34<sup>+&#x02005;</sup>OF and CD34<sup>&#x02013;</sup> OF were subjected to cytometric cell-sorting. As the data in <a href="/pmc/articles/PMC9516078/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4F</span></a> indicate, both basal and bTSH-induced (12-hour treatment) BAFF expression in the pure CD34<sup>&#x02013;</sup> OF subset are considerably higher than that in either parental cultures or pure CD34<sup>+&#x02005;</sup> OF.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC9516078/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139757116707600"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9516078_dgac415f0004.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is dgac415f0004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9516078/bin/dgac415f0004.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139757116707600"><a target="object" rel="noopener" href="/pmc/articles/PMC9516078/figure/F4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC9516078/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4.</a></div><!--caption a7--><div class="caption"><p>Effect of bTSH, teprotumumab, and Slit2 on BAFF expression in fibrocytes and GD-OF. (A,B) Cultures were treated for the graded intervals indicated along the abscissas with bTSH (5 mIU/mL). (A) Cellular RNA was harvested and subjected to reverse transcription by RT-PCR. Values were normalized to their respective GAPDH levels (B) Collected medium was assayed for BAFF levels with an ELISA, described in Methods. Values were normalized to respective monolayer protein content. Data are expressed as mean&#x02005;&#x000b1;&#x02005;SD of triplicate determinations; *<em>P</em>&#x02005;&#x0003c;&#x02005;0.05; **<em>P</em>&#x02005;&#x0003c;&#x02005;0.01; ***<em>P</em>&#x02005;&#x0003c;&#x02005;0.001. (C-F), bTSH for (12 hours), or teprotumumab (50 &#x000b5;g/mL) or rhSlit2 (50 ng/mL) was added for 7 days and analyzed for BAFF mRNA levels as in panel A. (C) Multiple culture strains were left untreated (-) or treated with bTSH for 12 hours. (D,E) Cultures of fibrocytes were treated with nothing, bTSH (12 hours), teprotumumab, or Slit2 or the combinations indicated. (F) Parental GD-OF strains were sorted into pure CD34<sup>+&#x02005;</sup>and CD34<sup>&#x02013;</sup> subsets using a FACSAria III instrument. Subsets were then cultured for 48 hour, the final 12 hours in the absence or presence of bTSH. Data were expressed as mean&#x02005;&#x000b1;&#x02005;SD of triplicate independent determinations from a single experiment representative of 3 conducted. *<em>P</em>&#x02005;&#x0003c;&#x02005;0.05; **<em>P</em>&#x02005;&#x0003c;&#x02005;0.01.</p></div></div></div></div><div id="s18" class="sec"><h3 id="s18title">Teprotumumab Enhances HA Synthesis in GD-OF and Fibrocytes</h3><p class="p p-first">A major component of tissue remodeling in TAO is HA accumulation in the orbit and upper face (<a href="#CIT0040" rid="CIT0040" class=" bibr popnode">40</a>). Among the clinical responses to teprotumumab in TAO is the dramatic reduction in proptosis accompanied by reductions in orbital connective tissue volumes (<a href="#CIT0014" rid="CIT0014" class=" bibr popnode">14</a>, <a href="#CIT0015" rid="CIT0015" class=" bibr popnode">15</a>). Because this increased volume can be attributed, at least in part, to disordered HA accumulation, effects of teprotumumab on HA generation were assessed in fibrocytes and GD-OF. Consistent with our earlier observations, HA synthesis was substantially greater in GD-OF than in fibrocytes (<a href="#CIT0025" rid="CIT0025" class=" bibr popnode">25</a>). Surprisingly, teprotumumab enhances the effects of bTSH on HA synthesis in GD-OF over 96 hours, the duration of the study (<a href="/pmc/articles/PMC9516078/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5A</span></a>). The synergism between bTSH and teprotumumab was also apparent in fibrocytes (<a href="/pmc/articles/PMC9516078/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5B</span></a>). Teprotumumab inhibits both basal and bTSH-provoked expression of HAS1 in fibrocytes and GD-OF (<a href="/pmc/articles/PMC9516078/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5C</span></a> and <a href="/pmc/articles/PMC9516078/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and5D,</span></span><span>5D</span></a>, respectively). In contrast, teprotumumab induces HAS2 expression, either as a single agent or in combination with bTSH in both cell types. The effects of teprotumumab on HAS1 and HAS2 expression are nearly identical to those of linsitinib (1 &#x000b5;M) (<a href="/pmc/articles/PMC9516078/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5E</span></a> and <a href="/pmc/articles/PMC9516078/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and5F).</span></span><span>5F</span></a>). We have previously demonstrated that HA production in fibrocytes and GD-OF is primarily the consequence of HAS2 expression and activity (<a href="#CIT0025" rid="CIT0025" class=" bibr popnode">25</a>, <a href="#CIT0026" rid="CIT0026" class=" bibr popnode">26</a>). Thus, teprotumumab exerts a small, direct, stimulatory effect on HA production in both fibrocytes and GD-OF through modest HAS2 induction. These effects are similar to those of linsitinib. It would appear that IGF-IR inhibition per se can increase in HAS2 levels and HA production in these cells. These findings therefore suggest that any inhibition of HA accumulation occurring in vivo by teprotumumab may be mediated through indirect actions, perhaps involving other cell types.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC9516078/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139757111421472"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9516078_dgac415f0005.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is dgac415f0005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9516078/bin/dgac415f0005.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139757111421472"><a target="object" rel="noopener" href="/pmc/articles/PMC9516078/figure/F5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC9516078/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Figure 5.</a></div><!--caption a7--><div class="caption"><p>Effect of teprotumumab on bTSH-induced HA production in (A) GD-OF and (B) fibrocytes. GD-OF were treated with or without teprotumumab (50 &#x000b5;g/mL) or human isotype IgG (5 &#x000b5;g/mL) for 7-9 days and stimulated with bTSH (5 mIU/mL) for graded intervals indicated along the abscissa for 0 to 96 hours. Media were collected and subjected to HA ELISA. Values were normalized to respective cell layer protein levels and expressed as the mean&#x02005;&#x000b1;&#x02005;SD of 3 independent determinations. Experiments were repeated 3 times. (C-F) Divergent pattern of HAS isoenzyme induction by bTSH in fibrocytes versus GD-OF and effects of (C,D) teprotumumab and (E,F) linsitinib. Confluent monolayers of GD-OF and fibrocytes remained untreated or received teprotumumab (50 &#x000b5;g/mL) or linsitinib (1 &#x000b5;M) and human Isotype IgG for 7-9 days. Some cultures were treated with bTSH (5 mIU/mL) for 6 hours. Cellular RNA was harvested, mRNA was reverse transcribed, and cDNA subjected to quantitative real-time PCR for HAS1 and HAS2. Values were normalized to their respective GAPDH levels and are expressed as the mean&#x02005;&#x000b1;&#x02005;SD of 3 independent determinations. Experiments were repeated 3 times. *<em>P</em>&#x02005;&#x0003c;&#x02005;0.05; **<em>P</em>&#x02005;&#x0003c;&#x02005;0.01; ***<em>P</em>&#x02005;&#x0003c;&#x02005;0.001.</p></div></div></div></div><div id="s19" class="sec sec-last"><h3 id="s19title">Could Effects of Teprotumumab Be Mediated Through the Slit2/ROBO1 Pathway?</h3><p class="p p-first">Slit2 exerts a powerful regulatory influence on fibrocyte differentiation (<a href="#CIT0041" rid="CIT0041" class=" bibr popnode">41</a>) and phenotype (<a href="#CIT0025" rid="CIT0025" class=" bibr popnode">25</a>, <a href="#CIT0030" rid="CIT0030" class=" bibr popnode">30</a>, <a href="#CIT0031" rid="CIT0031" class=" bibr popnode">31</a>). Moreover, these effects are mediated through its cognate membrane receptor, ROBO1. Because many of the effects exhibited by teprotumumab on fibrocytes resemble those of Slit2, we examined whether the monoclonal antibody might be influencing Slit2 and ROBO1 expression levels in GD-OF. Teprotumumab induces Slit2 protein synthesis in these cells (<a href="/pmc/articles/PMC9516078/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6A</span></a>). Further, it induces expression of both Slit2 mRNA and ROBO1 mRNA in 3 strains of GD-OF, each from a different donor (<a href="/pmc/articles/PMC9516078/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6B</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F6" co-legend-rid="lgnd_F6"><a href="/pmc/articles/PMC9516078/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139757109384816"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9516078_dgac415f0006.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is dgac415f0006.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC9516078/bin/dgac415f0006.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139757109384816"><a target="object" rel="noopener" href="/pmc/articles/PMC9516078/figure/F6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F6"><div><a class="figpopup" href="/pmc/articles/PMC9516078/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6">Figure 6.</a></div><!--caption a7--><div class="caption"><p>Teprotumumab induces Slit2 and ROBO1 mRNA and Slit2 protein in GD-OF. Cultures were treated with either isotype control IgG or teprotumumab (50 &#x000b5;g/mL) for 3 days. (A) Culture media were collected and subjected to Slit2-specific ELISA. Levels of Slit2 were normalized to respective cell layer protein content. (B) Cellular RNA was harvested from rinsed cell layers and mRNA reverse transcribed, and cDNA subjected to quantitative real-time PCR for Slit2 and ROBO1. Values were normalized to their respective GAPDH levels. **<em>P</em>&#x02005;&#x0003c;&#x02005;0.01, ***<em>P</em>&#x02005;&#x0003c;&#x02005;0.001.</p></div></div></div></div></div><div id="s20" class="tsec sec"><h2 class="head no_bottom_margin" id="s20title">Discussion</h2><p class="p p-first">Results from the current studies indicate that teprotumumab exerts several actions in vitro in fibrocytes and GD-OF. These findings may have revealed, at least in part, potentially important therapeutic mechanisms underlying the drug&#x02019;s clinical effectiveness in TAO. Several responses to TSHR activation, potentially related to disease pathogenesis, are attenuated by teprotumumab and another IGF-IR inhibitor, linsitinib. Further, the IGF-IR inhibitors also reduce basal (bTSH independent) expression of several proteins in fibrocytes and GD-OF. We previously found that teprotumumab reduces TSHR levels, but the effects are partial and transient (<a href="#CIT0029" rid="CIT0029" class=" bibr popnode">29</a>). Thus, in some cases, the effects of TSHR-initiated signaling are smaller in magnitude (ie, incomplete) than on others, potentially revealing the complex characteristics of the IGF-IR/TSHR signaling to specific gene targets. Of note subcellular IGF-IR distribution is markedly altered in lung fibroblasts from TSHR<sup>-/-</sup> mice (<a href="#CIT0042" rid="CIT0042" class=" bibr popnode">42</a>), demonstrating the reciprocal dependence of IGF-IR and TSHR pathways. We recently reported that teprotumumab and Slit2 downregulate expression of MHC II and multiple B7 costimulatory molecules in circulating fibrocytes, in vivo and in vitro (<a href="#CIT0017" rid="CIT0017" class=" bibr popnode">17</a>). Here, we find that teprotumumab attenuates basal expression of thyroid autoantigens including Tg, TPO, and NIS. In addition, the noncanonical transcription factor, AIRE, is also downregulated in these cells (<a href="/pmc/articles/PMC9516078/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig.1</span></a>). In contrast, effects of teprotumumab on induction by bTSH of these proteins are variable. The monoclonal antibody exerted small effects on TPO and NIS inductions while those of AIRE and Tg were strongly blunted. As suggested previously, TSHR signaling may comprise 2 components exhibiting IGF-IR dependence or independence (<a href="#CIT0043" rid="CIT0043" class=" bibr popnode">43</a>). Thus, susceptibility of specific bTSH-inducible proteins to therapeutic IGF-IR inhibition may differ, and therefore determine the patterns of clinical response. We have recently opined on the complex interplay between IGF-IR and TSHR that might underpin the diversity of IGF-IR-inhibitory effects on TSHR-initiated signaling (<a href="#CIT0044" rid="CIT0044" class=" bibr popnode">44</a>).</p><p>It is possible that the autoantigenic burden within the TAO orbit and in other tissues may be lessened by teprotumumab. Expression of these ectopically expressed thyroid proteins in circulating fibrocytes is under the positive control of AIRE (<a href="#CIT0023" rid="CIT0023" class=" bibr popnode">23</a>, <a href="#CIT0024" rid="CIT0024" class=" bibr popnode">24</a>). In contrast, lower levels of these antigens can be detected in CD34<sup>+&#x02005;</sup>OF (<a href="#CIT0030" rid="CIT0030" class=" bibr popnode">30</a>). Their divergent levels result, at least in part, from repression of gene activity in CD34<sup>+&#x02005;</sup>OF exerted by Slit2, emanating from residential CD34<sup>&#x02013;</sup> OF in situ in the TAO orbit. Thus, the impact of teprotumumab on fibrocyte and GD-OF phenotypes shares similarities with that of Slit2 (<a href="#CIT0030" rid="CIT0030" class=" bibr popnode">30</a>). Further, it is possible that the drug may be eliciting its clinical effects through reducing AIRE expression, perhaps within the thymus.</p><p>Besides its inhibition of AIRE and &#x0201c;thyroid-specific&#x0201d; proteins, teprotumumab also attenuates the expression and in some cases, the induction by bTSH of IL-23p19, IL-10, and BAFF in fibrocytes while enhancing that of IL-12p35, sIL-1RA, and icIL-1RA. The effects on IL-23 and IL-12 mirror those of Slit2 (<a href="#CIT0031" rid="CIT0031" class=" bibr popnode">31</a>). The inhibitory impact on BAFF is notable in light of recent evidence that serum BAFF levels and those of BAFF receptor 3 are elevated in GD (<a href="#CIT0045" rid="CIT0045" class=" bibr popnode">45</a>). Thus, in multiple regards, teprotumumab effects resemble those of Slit2 (<a href="#CIT0030" rid="CIT0030" class=" bibr popnode">30</a>, <a href="#CIT0031" rid="CIT0031" class=" bibr popnode">31</a>). The therapeutic monoclonal antibody&#x02019;s effects on HA synthesis mirror those of Slit2. This upregulation is mediated through increased HAS2 expression, the dominant isoenzyme expressed in GD-OF (<a href="#CIT0025" rid="CIT0025" class=" bibr popnode">25</a>, <a href="#CIT0026" rid="CIT0026" class=" bibr popnode">26</a>). At the same time, both Slit2 and teprotumumab downregulate HAS1 expression. From these findings, any impact of teprotumumab in reducing HA synthesis in vivo in TAO may be mediated indirectly, through actions in another cell-type(s), such as T cells. Earlier studies from our laboratory group have identified a potential for bidirectional interplay between T cells and fibrocytes, mediated through an extensive array of cytokines (<a href="#CIT0018" rid="CIT0018" class=" bibr popnode">18</a>, <a href="#CIT0029" rid="CIT0029" class=" bibr popnode">29</a>). It remains uncertain what effects, if any, teprotumumab might have on leukorgulin, CD40 ligand, IL-1&#x003b2;, and TNF-&#x003b1; synthesis or actions, cytokines known to drive HA synthesis in GD-OF (<a href="#CIT0046" rid="CIT0046" class=" bibr popnode">46-48</a>). Clearly, additional studies will be required to identify the mechanisms involved in the apparent clinical reduction by teprotumumab of HA-dependent water content within orbital tissues (<a href="#CIT0015" rid="CIT0015" class=" bibr popnode">15</a>). It remains possible that teprotumumab is directly affecting cytokine synthesis in T and B cells, in addition to its inhibition of IL-17a and interferon &#x003b3;, which is mediated indirectly through fibrocytes (<a href="#CIT0017" rid="CIT0017" class=" bibr popnode">17</a>).</p><p>Phenotypic differences between PBMC-derived CD34<sup>+&#x02005;</sup>fibrocytes and CD34<sup>+&#x02005;</sup>OF from TAO orbital tissue result in part from the actions of Slit2, generated primarily by CD34<sup>&#x02013;</sup> OF (<a href="#CIT0030" rid="CIT0030" class=" bibr popnode">30</a>, <a href="#CIT0031" rid="CIT0031" class=" bibr popnode">31</a>). Slit2 can downregulate specific genes while upregulating others in CD34<sup>+&#x02005;</sup>OF. Given the capacity for teprotumumab to induce both Slit2 and ROBO1 expression (<a href="/pmc/articles/PMC9516078/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6</span></a>), we now question whether at least some clinical responses attributed to teprotumumab might be mediated through intermediate induction of Slit2/ROBO1. We find the close alignment between teprotumumab and Slit2 effects on IL-23p19/IL-12p35 balance particularly interesting. Those findings suggest that IGF-IR-mediated signaling may influence T-cell polarization and expansion, particularly because Th1 and Th17 cytokines appear relevant to GD and TAO (<a href="#CIT0049" rid="CIT0049" class=" bibr popnode">49</a>, <a href="#CIT0050" rid="CIT0050" class=" bibr popnode">50</a>). The enhancing effects of teprotumumab on basal and TSH-provoked sIL-1RA and icIL-1RA suggest the potential for the drug to modulate consequences of inflammasome activation, a pathway we have previously implicated in TAO (<a href="#CIT0051" rid="CIT0051" class=" bibr popnode">51-53</a>). A recent study compared gene expression profiles in GD-OF and healthy orbital fibroblasts (<a href="#CIT0054" rid="CIT0054" class=" bibr popnode">54</a>). That report failed to include studies in purified CD34<sup>+&#x02005;</sup>OF and CD34<sup>&#x02013;</sup> OF, an approach that might have revealed additional divergence between gene expression repertoires of fibroblast subsets coming from healthy and TAO tissues.</p><p class="p p-last">Our current findings reveal additional, potentially important effects underlying responses to teprotumumab in TAO. It is possible that these may be mediated through Slit2, sIL-1RA, and icIL-1RA generation in GD-OF. Our studies have not included examination of other tissues and cell types but these are planned, conducted in vitro and in vivo. Despite these limitations, our results disclose potentially relevant insights into other diseases where fibrocytes and IGF-IR appear involved, such as rheumatoid arthritis (<a href="#CIT0055" rid="CIT0055" class=" bibr popnode">55</a>).</p></div><div id="a1" class="tsec sec"><h2 class="head no_bottom_margin" id="a1title">Acknowledgments</h2><div class="sec"><p>The authors are grateful to Ms. Dana Barnhart for her help in manuscript preparation. Teprotumumab was generously provided by River Vision and Horizon Therapeutics.</p></div></div><div id="glossary-a.k.b" class="tsec sec"><h2 class="head no_bottom_margin" id="glossary-a.k.btitle">Glossary</h2><div class="bk-sec"><div><h4>Abbreviations</h4><table class="default-table glossary"><tbody><tr><td>AIRE</td><td>autoimmune regulator protein</td></tr><tr><td>BAFF</td><td>B cell-activating factor</td></tr><tr><td>bTSH</td><td>bovine TSH</td></tr><tr><td>FBS</td><td>fetal bovine serum</td></tr><tr><td>GD</td><td>Graves&#x02019; disease</td></tr><tr><td>HA</td><td>hyaluronan</td></tr><tr><td>HAS</td><td>hyaluronan synthase</td></tr><tr><td>icIL-1RA</td><td>intracellular IL-1 receptor antagonist</td></tr><tr><td>NIS</td><td>sodium-iodide symporter</td></tr><tr><td>OF</td><td>orbital fibroblast</td></tr><tr><td>PBMC</td><td>peripheral blood mononuclear cell</td></tr><tr><td>ROBO1</td><td>roundabout 1</td></tr><tr><td>sIL-IRA</td><td>secreted IL-1 receptor antagonist</td></tr><tr><td>TAO</td><td>thyroid-associated ophthalmopathy</td></tr><tr><td>Tg</td><td>thyroglobulin</td></tr><tr><td>TPO</td><td>thyroperoxidase</td></tr><tr><td>TS1</td><td>thyroid-stimulating immunoglobulin</td></tr><tr><td>TSHR</td><td>thyrotropin receptor</td></tr></tbody></table></div></div></div><div id="article-aaff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="article-aaff-infotitle">Contributor Information</h2><p><span class="fm-affl">Roshini Fernando, </span><span class="fm-affl" id="aff-a.i.b.f.a.b"> 
Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, Ann Arbor, MI 48105, USA.</span><span class="fm-affl" id="aff-a.i.b.f.a.c"> 
Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105, USA.</span></p><p><span class="fm-affl">Terry J Smith, </span><span class="fm-affl" id="aff-a.i.b.f.b.c"> 
Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, Ann Arbor, MI 48105, USA.</span><span class="fm-affl" id="aff-a.i.b.f.b.d"> 
Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105, USA.</span></p></div><div id="s21" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="s21title">Funding</h2><!--/article/back/sec/--><p class="p p-first-last">This work was supported in part by NIH grants R01 EY008976, NIH Autoimmune Center of Excellence grant AR088974, NEI Core grant EY007003, and Research to Prevent Blindness.</p></div><div id="s22" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="s22title">Disclosures</h2><!--/article/back/sec/--><p class="p p-first-last">T.J.S. was issued patents covering treatment of TAO and other autoimmune diseases with inhibitors of the IGF-I receptor. These are held by UCLA/Los Angeles Biomedical Foundation/Lundquist Institute. He is a paid consultant for Horizon Therapeutics, Veridian and Immunovant.</p></div><div id="s23" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="s23title">Data Availability</h2><!--/article/back/sec/--><p class="p p-first-last">Original data generated and analyzed during this study are included in this published article or in the data repositories listed in References.</p></div><div id="r1" class="tsec sec"><h2 class="head no_bottom_margin" id="r1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CIT0001">1. <span class="mixed-citation">
Kazim M, Goldberg RA, Smith TJ. <span class="ref-title">Insights into the pathogenesis of thyroid-associated orbitopathy: evolving rationale for therapy</span>. <span class="ref-journal">Arch Ophthalmol.</span> 2002;<span class="ref-vol">120</span>(3):380-386. [<a href="https://pubmed.ncbi.nlm.nih.gov/11879144" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Ophthalmol.&amp;title=Insights+into+the+pathogenesis+of+thyroid-associated+orbitopathy:+evolving+rationale+for+therapy&amp;volume=120&amp;publication_year=2002&amp;pages=380-386&amp;pmid=11879144&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0002">2. <span class="mixed-citation">
Smith TJ, Hegedus L. <span class="ref-title">Graves&#x02019; disease</span>. <span class="ref-journal">N Engl J Med.</span> 2016;<span class="ref-vol">375</span>(6):1552-1565. [<a href="https://pubmed.ncbi.nlm.nih.gov/27797318" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med.&amp;title=Graves&#x02019;+disease&amp;volume=375&amp;publication_year=2016&amp;pages=1552-1565&amp;pmid=27797318&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0003">3. <span class="mixed-citation">
Feliciello A, Porcellini A, Ciullo I, Bonavolonta G, Avvedimento EV, Fenzi G. <span class="ref-title">Expression of thyrotropin-receptor mRNA in healthy and Graves&#x02019; disease retro-orbital tissue</span>. <span class="ref-journal">Lancet.</span> 1993;<span class="ref-vol">342</span>(8867):337-338. [<a href="https://pubmed.ncbi.nlm.nih.gov/8101586" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet.&amp;title=Expression+of+thyrotropin-receptor+mRNA+in+healthy+and+Graves&#x02019;+disease+retro-orbital+tissue&amp;volume=342&amp;publication_year=1993&amp;pages=337-338&amp;pmid=8101586&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0004">4. <span class="mixed-citation">
Heufelder AE, Dutton CM, Sarkar G, Donovan KA, Bahn RS. <span class="ref-title">Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves&#x02019; ophthalmopathy and pretibial dermopathy</span>. <span class="ref-journal">Thyroid.</span> 1993;<span class="ref-vol">3</span>(4):297-300. [<a href="https://pubmed.ncbi.nlm.nih.gov/7509671" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Thyroid.&amp;title=Detection+of+TSH+receptor+RNA+in+cultured+fibroblasts+from+patients+with+Graves&#x02019;+ophthalmopathy+and+pretibial+dermopathy&amp;volume=3&amp;publication_year=1993&amp;pages=297-300&amp;pmid=7509671&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0005">5. <span class="mixed-citation">
Smith TJ, Hoa N. <span class="ref-title">Immunoglobulins from patients with Graves&#x02019; disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor</span>. <span class="ref-journal">J Clin Endocrinol Metab.</span> 2004;<span class="ref-vol">89</span>(10):5076-5080. [<a href="https://pubmed.ncbi.nlm.nih.gov/15472208" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab.&amp;title=Immunoglobulins+from+patients+with+Graves&#x02019;+disease+induce+hyaluronan+synthesis+in+their+orbital+fibroblasts+through+the+self-antigen,+insulin-like+growth+factor-I+receptor&amp;volume=89&amp;publication_year=2004&amp;pages=5076-5080&amp;pmid=15472208&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0006">6. <span class="mixed-citation">
Douglas RS, Afifiyan NF, Hwang CJ, et al.. 
<span class="ref-title">Increased generation of fibrocytes in thyroid-associated ophthalmopathy</span>. <span class="ref-journal">J Clin Endocrinol Metab.</span> 2010;<span class="ref-vol">95</span>(1):430-438. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2805489/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19897675" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab.&amp;title=Increased+generation+of+fibrocytes+in+thyroid-associated+ophthalmopathy&amp;volume=95&amp;publication_year=2010&amp;pages=430-438&amp;pmid=19897675&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0007">7. <span class="mixed-citation">
Kumar S, Schiefer R, Coenen MJ, Bahn RS. <span class="ref-title">A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves&#x02019; orbital preadipocyte fibroblasts</span>. <span class="ref-journal">Thyroid.</span> 2010;<span class="ref-vol">20</span>(1):59-65. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2833174/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20017620" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Thyroid.&amp;title=A+stimulatory+thyrotropin+receptor+antibody+(M22)+and+thyrotropin+increase+interleukin-6+expression+and+secretion+in+Graves&#x02019;+orbital+preadipocyte+fibroblasts&amp;volume=20&amp;publication_year=2010&amp;pages=59-65&amp;pmid=20017620&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0008">8. <span class="mixed-citation">
Ponto KA, Diana T, Binder H, et al.. 
<span class="ref-title">Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy</span>. <span class="ref-journal">J Endocrinol Invest.</span> 2015;<span class="ref-vol">38</span>(7):769-777. [<a href="https://pubmed.ncbi.nlm.nih.gov/25736545" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Endocrinol+Invest.&amp;title=Thyroid-stimulating+immunoglobulins+indicate+the+onset+of+dysthyroid+optic+neuropathy&amp;volume=38&amp;publication_year=2015&amp;pages=769-777&amp;pmid=25736545&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0009">9. <span class="mixed-citation">
Woo YJ, Jang SY, Lim TH, Yoon JS. <span class="ref-title">Clinical association of thyroid stimulating hormone receptor antibody levels with disease severity in the chronic inactive stage of Graves&#x02019; orbitopathy</span>. <span class="ref-journal">Korean J Ophthalmol.</span> 2015;<span class="ref-vol">29</span>(4):213-219. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4520863/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26240504" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Korean+J+Ophthalmol.&amp;title=Clinical+association+of+thyroid+stimulating+hormone+receptor+antibody+levels+with+disease+severity+in+the+chronic+inactive+stage+of+Graves&#x02019;+orbitopathy&amp;volume=29&amp;publication_year=2015&amp;pages=213-219&amp;pmid=26240504&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0010">10. <span class="mixed-citation">
Tsui S, Naik V, Hoa N, et al.. 
<span class="ref-title">Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves&#x02019; disease</span>. <span class="ref-journal">J Immunol.</span> 2008;<span class="ref-vol">181</span>(6):4397-4405. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2775538/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18768899" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol.&amp;title=Evidence+for+an+association+between+thyroid-stimulating+hormone+and+insulin-like+growth+factor+1+receptors:+a+tale+of+two+antigens+implicated+in+Graves&#x02019;+disease&amp;volume=181&amp;publication_year=2008&amp;pages=4397-4405&amp;pmid=18768899&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0011">11. <span class="mixed-citation">
Pritchard J, Horst N, Cruikshank W, Smith TJ. <span class="ref-title">Igs from patients with Graves&#x02019; disease induce the expression of T cell chemoattractants in their fibroblasts</span>. <span class="ref-journal">J Immunol.</span> 2002;<span class="ref-vol">168</span>(2):942-950. [<a href="https://pubmed.ncbi.nlm.nih.gov/11777993" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol.&amp;title=Igs+from+patients+with+Graves&#x02019;+disease+induce+the+expression+of+T+cell+chemoattractants+in+their+fibroblasts&amp;volume=168&amp;publication_year=2002&amp;pages=942-950&amp;pmid=11777993&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0012">12. <span class="mixed-citation">
Pritchard J, Han R, Horst N, Cruikshank WW, Smith TJ. <span class="ref-title">Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves&#x02019; disease is mediated through the insulin-like growth factor I receptor pathway</span>. <span class="ref-journal">J Immunol.</span> 2003;<span class="ref-vol">170</span>(12):6348-6354. [<a href="https://pubmed.ncbi.nlm.nih.gov/12794168" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol.&amp;title=Immunoglobulin+activation+of+T+cell+chemoattractant+expression+in+fibroblasts+from+patients+with+Graves&#x02019;+disease+is+mediated+through+the+insulin-like+growth+factor+I+receptor+pathway&amp;volume=170&amp;publication_year=2003&amp;pages=6348-6354&amp;pmid=12794168&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0013">13. <span class="mixed-citation">
Smith TJ, Janssen J. <span class="ref-title">Response to Krieger <em>et al</em>. re: &#x0201c;TSHR/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves&#x02019; Ophthalmopathy Pathogenesis&#x0201d; (Thyroid 2017;27:746-747)</span>. <span class="ref-journal">Thyroid.</span> 2017;<span class="ref-vol">27</span>(11):1458. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5672619/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28847224" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Thyroid.&amp;title=Response+to+Krieger+et+al.+re:+&#x0201c;TSHR/IGF-1R+Cross-Talk,+Not+IGF-1R+Stimulating+Antibodies,+Mediates+Graves&#x02019;+Ophthalmopathy+Pathogenesis&#x0201d;+(Thyroid+2017;27:746-747)&amp;volume=27&amp;publication_year=2017&amp;pages=1458&amp;pmid=28847224&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0014">14. <span class="mixed-citation">
Smith TJ, Kahaly GJ, Ezra DG, et al.. 
<span class="ref-title">Teprotumumab for thyroid-associated ophthalmopathy</span>. <span class="ref-journal">N Engl J Med.</span> 2017;<span class="ref-vol">376</span>(18):1748-1761. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5718164/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28467880" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med.&amp;title=Teprotumumab+for+thyroid-associated+ophthalmopathy&amp;volume=376&amp;publication_year=2017&amp;pages=1748-1761&amp;pmid=28467880&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0015">15. <span class="mixed-citation">
Douglas RS, Kahaly GJ, Patel A, et al.. 
<span class="ref-title">Teprotumumab for the treatment of active thyroid eye disease</span>. <span class="ref-journal">N Engl J Med.</span> 2020;<span class="ref-vol">382</span>(4):341-352. [<a href="https://pubmed.ncbi.nlm.nih.gov/31971679" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med.&amp;title=Teprotumumab+for+the+treatment+of+active+thyroid+eye+disease&amp;volume=382&amp;publication_year=2020&amp;pages=341-352&amp;pmid=31971679&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0016">16. <span class="mixed-citation">
Markham A. <span class="ref-title">Teprotumumab: first approval</span>. <span class="ref-journal">Drugs.</span> 2020;<span class="ref-vol">80</span>(5):509-512. [<a href="https://pubmed.ncbi.nlm.nih.gov/32157641" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drugs.&amp;title=Teprotumumab:+first+approval&amp;volume=80&amp;publication_year=2020&amp;pages=509-512&amp;pmid=32157641&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0017">17. <span class="mixed-citation">
Fernando R, Caldera O, Smith TJ. <span class="ref-title">Therapeutic IGF-I receptor inhibition alters fibrocyte immune phenotype in thyroid-associated ophthalmopathy</span>. <span class="ref-journal">Proc Natl Acad Sci USA.</span> 2021;118(52):e2114244118. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8719891/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34949642" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA.&amp;title=Therapeutic+IGF-I+receptor+inhibition+alters+fibrocyte+immune+phenotype+in+thyroid-associated+ophthalmopathy&amp;publication_year=2021&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0018">18. <span class="mixed-citation">
Smith TJ. <span class="ref-title">TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy</span>. <span class="ref-journal">Nat Rev Endocrinol.</span> 2015;<span class="ref-vol">11</span>(13):171-181. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4687015/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25560705" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Endocrinol.&amp;title=TSH-receptor-expressing+fibrocytes+and+thyroid-associated+ophthalmopathy&amp;volume=11&amp;publication_year=2015&amp;pages=171-181&amp;pmid=25560705&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0019">19. <span class="mixed-citation">
Smith TJ, Sempowski GD, Wang HS, Del Vecchio PJ, Lippe SD, Phipps RP. <span class="ref-title">Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts</span>. <span class="ref-journal">J Clin Endocrinol Metab.</span> 1995;<span class="ref-vol">80</span>(9):2620-2625. [<a href="https://pubmed.ncbi.nlm.nih.gov/7673404" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab.&amp;title=Evidence+for+cellular+heterogeneity+in+primary+cultures+of+human+orbital+fibroblasts&amp;volume=80&amp;publication_year=1995&amp;pages=2620-2625&amp;pmid=7673404&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0020">20. <span class="mixed-citation">
Smith TJ, Koumas L, Gagnon A, et al.. 
<span class="ref-title">Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy</span>. <span class="ref-journal">J Clin Endocrinol Metab.</span> 2002;<span class="ref-vol">87</span>(1):385-392. [<a href="https://pubmed.ncbi.nlm.nih.gov/11788681" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab.&amp;title=Orbital+fibroblast+heterogeneity+may+determine+the+clinical+presentation+of+thyroid-associated+ophthalmopathy&amp;volume=87&amp;publication_year=2002&amp;pages=385-392&amp;pmid=11788681&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0021">21. <span class="mixed-citation">
Smith TJ. <span class="ref-title">Potential roles of CD34+ fibrocytes masquerading as orbital fibroblasts in thyroid-associated ophthalmopathy</span>. <span class="ref-journal">J Clin Endocrinol Metab.</span> 2019;<span class="ref-vol">104</span>(2):581-594. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6320239/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30445529" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab.&amp;title=Potential+roles+of+CD34++fibrocytes+masquerading+as+orbital+fibroblasts+in+thyroid-associated+ophthalmopathy&amp;volume=104&amp;publication_year=2019&amp;pages=581-594&amp;pmid=30445529&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0022">22. <span class="mixed-citation">
Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. <span class="ref-title">Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair</span>. <span class="ref-journal">Mol Med.</span> 1994;<span class="ref-vol">1</span>(1):71-81. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2229929/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8790603" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Med.&amp;title=Circulating+fibrocytes+define+a+new+leukocyte+subpopulation+that+mediates+tissue+repair&amp;volume=1&amp;publication_year=1994&amp;pages=71-81&amp;pmid=8790603&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0023">23. <span class="mixed-citation">
Fernando R, Atkins S, Raychaudhuri N, et al.. 
<span class="ref-title">Human fibrocytes coexpress thyroglobulin and thyrotropin receptor</span>. <span class="ref-journal">Proc Natl Acad Sci USA.</span> 2012;<span class="ref-vol">109</span>(19):7427-7432. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3358913/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22517745" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA.&amp;title=Human+fibrocytes+coexpress+thyroglobulin+and+thyrotropin+receptor&amp;volume=109&amp;publication_year=2012&amp;pages=7427-7432&amp;pmid=22517745&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0024">24. <span class="mixed-citation">
Fernando R, Lu Y, Atkins SJ, Mester T, Branham K, Smith TJ. <span class="ref-title">Expression of thyrotropin receptor, thyroglobulin, sodium-iodide symporter, and thyroperoxidase by fibrocytes depends on AIRE</span>. <span class="ref-journal">J Clin Endocrinol Metab.</span> 2014;<span class="ref-vol">99</span>(7):E1236-E1244. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4079309/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24708100" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab.&amp;title=Expression+of+thyrotropin+receptor,+thyroglobulin,+sodium-iodide+symporter,+and+thyroperoxidase+by+fibrocytes+depends+on+AIRE&amp;volume=99&amp;publication_year=2014&amp;pages=E1236-E1244&amp;pmid=24708100&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0025">25. <span class="mixed-citation">
Fernando R, Smith TJ. <span class="ref-title">Slit2 regulates hyaluronan &#x00026; cytokine synthesis in fibrocytes: Potential relevance to thyroid associated ophthalmopathy</span>. <span class="ref-journal">J Clin Endocrinol Metab.</span> 2020;106(1):e20-e33. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7765649/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32968816" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab.&amp;title=Slit2+regulates+hyaluronan+&#x00026;+cytokine+synthesis+in+fibrocytes:+Potential+relevance+to+thyroid+associated+ophthalmopathy&amp;publication_year=2020&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0026">26. <span class="mixed-citation">
Kaback LA, Smith TJ. <span class="ref-title">Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1beta in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy</span>. <span class="ref-journal">J Clin Endocrinol Metab.</span> 1999;<span class="ref-vol">84</span>(11):4079-4084. [<a href="https://pubmed.ncbi.nlm.nih.gov/10566653" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab.&amp;title=Expression+of+hyaluronan+synthase+messenger+ribonucleic+acids+and+their+induction+by+interleukin-1beta+in+human+orbital+fibroblasts:+potential+insight+into+the+molecular+pathogenesis+of+thyroid-associated+ophthalmopathy&amp;volume=84&amp;publication_year=1999&amp;pages=4079-4084&amp;pmid=10566653&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0027">27. <span class="mixed-citation">
Spicer AP, Kaback LA, Smith TJ, Seldin MF. <span class="ref-title">Molecular cloning and characterization of the human and mouse UDP-glucose dehydrogenase genes</span>. <span class="ref-journal">J Biol Chem.</span> 1998;<span class="ref-vol">273</span>(39):25117-25124. [<a href="https://pubmed.ncbi.nlm.nih.gov/9737970" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem.&amp;title=Molecular+cloning+and+characterization+of+the+human+and+mouse+UDP-glucose+dehydrogenase+genes&amp;volume=273&amp;publication_year=1998&amp;pages=25117-25124&amp;pmid=9737970&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0028">28. <span class="mixed-citation">
Tsui S, Fernando R, Chen B, Smith TJ. <span class="ref-title">Divergent Sp1 protein levels may underlie differential expression of UDP-glucose dehydrogenase by fibroblasts: role in susceptibility to orbital Graves disease</span>. <span class="ref-journal">J Biol Chem.</span> 2011;<span class="ref-vol">286</span>:24487-24499. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3129228/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21576248" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem.&amp;title=Divergent+Sp1+protein+levels+may+underlie+differential+expression+of+UDP-glucose+dehydrogenase+by+fibroblasts:+role+in+susceptibility+to+orbital+Graves+disease&amp;volume=286&amp;publication_year=2011&amp;pages=24487-24499&amp;pmid=21576248&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0029">29. <span class="mixed-citation">
Chen H, Mester T, Raychaudhuri N, et al.. 
<span class="ref-title">Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes</span>. <span class="ref-journal">J Clin Endocrinol Metab.</span> 2014;<span class="ref-vol">99</span>(9): E1635-E1640. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4154099/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24878056" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab.&amp;title=Teprotumumab,+an+IGF-1R+blocking+monoclonal+antibody+inhibits+TSH+and+IGF-1+action+in+fibrocytes&amp;volume=99&amp;publication_year=2014&amp;pages=E1635-E1640&amp;pmid=24878056&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0030">30. <span class="mixed-citation">
Fernando R, Grisolia ABD, Lu Y, Atkins S, Smith TJ. <span class="ref-title">Slit2 modulates the inflammatory phenotype of orbit-infiltrating fibrocytes in Graves&#x02019; disease</span>. <span class="ref-journal">J Immunol.</span> 2018;<span class="ref-vol">200</span>(12):3942-3949. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6070359/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29752312" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol.&amp;title=Slit2+modulates+the+inflammatory+phenotype+of+orbit-infiltrating+fibrocytes+in+Graves&#x02019;+disease&amp;volume=200&amp;publication_year=2018&amp;pages=3942-3949&amp;pmid=29752312&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0031">31. <span class="mixed-citation">
Fernando R, Atkins SJ, Smith TJ. <span class="ref-title">Slit2 may underlie divergent induction by thyrotropin of IL-23 and IL-12 in human fibrocytes</span>. <span class="ref-journal">J Immunol.</span> 2020;<span class="ref-vol">204</span>(7):1724-1735. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7365299/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32086386" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol.&amp;title=Slit2+may+underlie+divergent+induction+by+thyrotropin+of+IL-23+and+IL-12+in+human+fibrocytes&amp;volume=204&amp;publication_year=2020&amp;pages=1724-1735&amp;pmid=32086386&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0032">32. <span class="mixed-citation">
Fernando R, Smith TJ. <span class="ref-title">Slit2 regulates hyaluronan &#x00026; cytokine synthesis in fibrocytes: potential relevance to thyroid-associated ophthalmopathy</span>. <span class="ref-journal">J Clin Endocrinol Metab.</span> 2021;<span class="ref-vol">106</span>(1):e20-e33. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7765649/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32968816" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab.&amp;title=Slit2+regulates+hyaluronan+&#x00026;+cytokine+synthesis+in+fibrocytes:+potential+relevance+to+thyroid-associated+ophthalmopathy&amp;volume=106&amp;publication_year=2021&amp;pages=e20-e33&amp;pmid=32968816&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0033">33. <span class="mixed-citation">
Smith TJ. <span class="ref-title">Role of orbital fat in thyroid-associated ophthalmopathy. Graves&#x02019; Associated Orbital Disease.</span> in <span class="ref-journal">Thyroid Eye Disease: Diagnosis and Treatment</span>. (Dutton, J. J., and Haik, B. G. eds.), 
Marcel Dekker, Inc. Publishers, New York, NY. 2002; (5) 
215-221. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Thyroid+Eye+Disease:+Diagnosis+and+Treatment&amp;publication_year=2002&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0034">34. <span class="mixed-citation">
Smith TJ, Bahn RS, Gorman CA. <span class="ref-title">Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: evidence for differences between retroocular and dermal fibroblasts</span>. <span class="ref-journal">J Clin Endocrinol Metab.</span> 1989;<span class="ref-vol">69</span>(7):1019-1023. [<a href="https://pubmed.ncbi.nlm.nih.gov/2793988" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab.&amp;title=Hormonal+regulation+of+hyaluronate+synthesis+in+cultured+human+fibroblasts:+evidence+for+differences+between+retroocular+and+dermal+fibroblasts&amp;volume=69&amp;publication_year=1989&amp;pages=1019-1023&amp;pmid=2793988&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0035">35. <span class="mixed-citation">
Gyulveszi G, Haak S, Becher B. <span class="ref-title">IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation <em>in vivo</em></span>. <span class="ref-journal">Eur J Immunol.</span> 2009;<span class="ref-vol">39</span>:1864-1869. [<a href="https://pubmed.ncbi.nlm.nih.gov/19544494" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Immunol.&amp;title=IL-23-driven+encephalo-tropism+and+Th17+polarization+during+CNS-inflammation+in+vivo&amp;volume=39&amp;publication_year=2009&amp;pages=1864-1869&amp;pmid=19544494&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0036">36. <span class="mixed-citation">
Mosmann TR. <span class="ref-title">Role of a new cytokine, interleukin-10, in the cross-regulation of T helper cells</span>. <span class="ref-journal">Ann N Y Acad Sci.</span> 1991;<span class="ref-vol">628</span>:337-344. [<a href="https://pubmed.ncbi.nlm.nih.gov/1648883" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+N+Y+Acad+Sci.&amp;title=Role+of+a+new+cytokine,+interleukin-10,+in+the+cross-regulation+of+T+helper+cells&amp;volume=628&amp;publication_year=1991&amp;pages=337-344&amp;pmid=1648883&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0037">37. <span class="mixed-citation">
Barthlott T, Moncrieffe H, Veldhoen M, et al.. 
<span class="ref-title">CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production</span>. <span class="ref-journal">Int Immunol.</span> 2005;<span class="ref-vol">17</span>(3):279-288. [<a href="https://pubmed.ncbi.nlm.nih.gov/15684039" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+Immunol.&amp;title=CD25++CD4++T+cells+compete+with+naive+CD4++T+cells+for+IL-2+and+exploit+it+for+the+induction+of+IL-10+production&amp;volume=17&amp;publication_year=2005&amp;pages=279-288&amp;pmid=15684039&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0038">38. <span class="mixed-citation">
Mackay F, Browning JL. <span class="ref-title">BAFF: a fundamental survival factor for B cells</span>. <span class="ref-journal">Nat Rev Immunol.</span> 2002;<span class="ref-vol">2</span>(7):465-475. [<a href="https://pubmed.ncbi.nlm.nih.gov/12094221" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Immunol.&amp;title=BAFF:+a+fundamental+survival+factor+for+B+cells&amp;volume=2&amp;publication_year=2002&amp;pages=465-475&amp;pmid=12094221&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0039">39. <span class="mixed-citation">
Kalled SL. <span class="ref-title">BAFF: a novel therapeutic target for autoimmunity</span>. <span class="ref-journal">Curr Opin Investig Drugs </span> 2002;<span class="ref-vol">3</span>(7):1005-1010. [<a href="https://pubmed.ncbi.nlm.nih.gov/12186259" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Investig+Drugs+&amp;title=BAFF:+a+novel+therapeutic+target+for+autoimmunity&amp;volume=3&amp;publication_year=2002&amp;pages=1005-1010&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0040">40. <span class="mixed-citation">
Smith TJ, Bahn RS, Gorman CA. <span class="ref-title">Connective tissue, glycosaminoglycans, and diseases of the thyroid</span>. <span class="ref-journal">Endocr Rev.</span> 1989;<span class="ref-vol">10</span>(3):366-391. [<a href="https://pubmed.ncbi.nlm.nih.gov/2673756" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Rev.&amp;title=Connective+tissue,+glycosaminoglycans,+and+diseases+of+the+thyroid&amp;volume=10&amp;publication_year=1989&amp;pages=366-391&amp;pmid=2673756&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0041">41. <span class="mixed-citation">
Pilling D, Zheng Z, Vakil V, Gomer RH. <span class="ref-title">Fibroblasts secrete Slit2 to inhibit fibrocyte differentiation and fibrosis</span>. <span class="ref-journal">Proc Natl Acad Sci USA.</span> 2014;<span class="ref-vol">111</span>(51):18291-18296. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4280645/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25489114" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA.&amp;title=Fibroblasts+secrete+Slit2+to+inhibit+fibrocyte+differentiation+and+fibrosis&amp;volume=111&amp;publication_year=2014&amp;pages=18291-18296&amp;pmid=25489114&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0042">42. <span class="mixed-citation">
Atkins SJ, Lentz SI, Fernando R, Smith TJ. <span class="ref-title">Disrupted TSH receptor expression in female mouse lung fibroblasts alters subcellular IGF-1 receptor distribution</span>. <span class="ref-journal">Endocrinology.</span> 2015;<span class="ref-vol">156</span>(12):4731-4740. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4655214/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26389690" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology.&amp;title=Disrupted+TSH+receptor+expression+in+female+mouse+lung+fibroblasts+alters+subcellular+IGF-1+receptor+distribution&amp;volume=156&amp;publication_year=2015&amp;pages=4731-4740&amp;pmid=26389690&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0043">43. <span class="mixed-citation">
Krieger CC, Neumann S, Place RF, Marcus-Samuels B, Gershengorn MC. <span class="ref-title">Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves&#x02019; disease immunoglobins</span>. <span class="ref-journal">J Clin Endocrinol Metab.</span> 2015;<span class="ref-vol">100</span>(3):1071-1077. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4333041/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25485727" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab.&amp;title=Bidirectional+TSH+and+IGF-1+receptor+cross+talk+mediates+stimulation+of+hyaluronan+secretion+by+Graves&#x02019;+disease+immunoglobins&amp;volume=100&amp;publication_year=2015&amp;pages=1071-1077&amp;pmid=25485727&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0044">44. <span class="mixed-citation">
Girnita L, Smith TJ, Janssen JAMJL. <span class="ref-title">It takes two to tango: IGF-I and TSH receptors in thyroid eye disease</span>. <span class="ref-journal">J Clin Endocrinol Metab</span>. 2022, dgac045. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9359450/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35167695" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=It+takes+two+to+tango:+IGF-I+and+TSH+receptors+in+thyroid+eye+disease&amp;publication_year=2022&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0045">45. <span class="mixed-citation">
Wang X, Huang J, Zhang A, Fang C, Ma Q, Jiang P. <span class="ref-title">Altered expression profile of BAFF receptors on peripheral blood B lymphocytes in Graves&#x02019; disease</span>. <span class="ref-journal">BMC Endocr. Disord</span>. 2021;<span class="ref-vol">21</span>(1):88. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8082831/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33926416" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Endocr.+Disord&amp;title=Altered+expression+profile+of+BAFF+receptors+on+peripheral+blood+B+lymphocytes+in+Graves&#x02019;+disease&amp;volume=21&amp;publication_year=2021&amp;pages=88&amp;pmid=33926416&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0046">46. <span class="mixed-citation">
Smith TJ, Wang HS, Evans CH. <span class="ref-title">Leukoregulin is a potent inducer of hyaluronan synthesis in cultured human orbital fibroblasts</span>. <span class="ref-journal">Am J Physiol.</span> 1995;<span class="ref-vol">268</span>(2):C382-C388. [<a href="https://pubmed.ncbi.nlm.nih.gov/7864077" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol.&amp;title=Leukoregulin+is+a+potent+inducer+of+hyaluronan+synthesis+in+cultured+human+orbital+fibroblasts&amp;volume=268&amp;publication_year=1995&amp;pages=C382-C388&amp;pmid=7864077&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0047">47. <span class="mixed-citation">
Cao HJ, Wang HS, Zhang Y, Lin HY, Phipps RP, Smith TJ. <span class="ref-title">Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression. Insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy</span>. <span class="ref-journal">J Biol Chem.</span> 1998;<span class="ref-vol">273</span>(45):29615-29625. [<a href="https://pubmed.ncbi.nlm.nih.gov/9792671" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem.&amp;title=Activation+of+human+orbital+fibroblasts+through+CD40+engagement+results+in+a+dramatic+induction+of+hyaluronan+synthesis+and+prostaglandin+endoperoxide+H+synthase-2+expression.+Insights+into+potential+pathogenic+mechanisms+of+thyroid-associated+ophthalmopathy&amp;volume=273&amp;publication_year=1998&amp;pages=29615-29625&amp;pmid=9792671&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0048">48. <span class="mixed-citation">
Spicer AP, McDonald JA. <span class="ref-title">Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family</span>. <span class="ref-journal">J Biol Chem.</span> 1998;<span class="ref-vol">273</span>(4):1923-1932. [<a href="https://pubmed.ncbi.nlm.nih.gov/9442026" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem.&amp;title=Characterization+and+molecular+evolution+of+a+vertebrate+hyaluronan+synthase+gene+family&amp;volume=273&amp;publication_year=1998&amp;pages=1923-1932&amp;pmid=9442026&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0049">49. <span class="mixed-citation">
Fang S, Huang Y, Wang N, et al.. 
<span class="ref-title">Insights into local orbital immunity: evidence for the involvement of the Th17 cell pathway in thyroid-associated ophthalmopathy</span>. <span class="ref-journal">J Clin Endocrinol Metab.</span> 2019;<span class="ref-vol">104</span>(5):1697-1711. [<a href="https://pubmed.ncbi.nlm.nih.gov/30517642" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab.&amp;title=Insights+into+local+orbital+immunity:+evidence+for+the+involvement+of+the+Th17+cell+pathway+in+thyroid-associated+ophthalmopathy&amp;volume=104&amp;publication_year=2019&amp;pages=1697-1711&amp;pmid=30517642&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0050">50. <span class="mixed-citation">
Pan Y, Wang M, Chen X, et al.. 
<span class="ref-title">Elevated IL-38 inhibits IL-23R expression and IL-17A production in thyroid-associated ophthalmopathy</span>. <span class="ref-journal">Int Immunopharmacol.</span> 2021;<span class="ref-vol">91</span>:107300. [<a href="https://pubmed.ncbi.nlm.nih.gov/33383445" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+Immunopharmacol.&amp;title=Elevated+IL-38+inhibits+IL-23R+expression+and+IL-17A+production+in+thyroid-associated+ophthalmopathy&amp;volume=91&amp;publication_year=2021&amp;pages=107300&amp;pmid=33383445&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0051">51. <span class="mixed-citation">
Li B, Smith TJ. <span class="ref-title">Divergent expression of IL-1 receptor antagonists in CD34(+) fibrocytes and orbital fibroblasts in thyroid-associated ophthalmopathy: contribution of fibrocytes to orbital inflammation</span>. <span class="ref-journal">J Clin Endocrinol Metab.</span> 2013;<span class="ref-vol">98</span>(7):2783-2790. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3701275/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23633206" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab.&amp;title=Divergent+expression+of+IL-1+receptor+antagonists+in+CD34(+)+fibrocytes+and+orbital+fibroblasts+in+thyroid-associated+ophthalmopathy:+contribution+of+fibrocytes+to+orbital+inflammation&amp;volume=98&amp;publication_year=2013&amp;pages=2783-2790&amp;pmid=23633206&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0052">52. <span class="mixed-citation">
Li B, Smith TJ. <span class="ref-title">PI3K/AKT pathway mediates induction of IL-1RA by TSH in fibrocytes: modulation by PTEN</span>. <span class="ref-journal">J Clin Endocrinol Metab.</span> 2014;<span class="ref-vol">99</span>(9):3363-3372. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4154109/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24840811" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab.&amp;title=PI3K/AKT+pathway+mediates+induction+of+IL-1RA+by+TSH+in+fibrocytes:+modulation+by+PTEN&amp;volume=99&amp;publication_year=2014&amp;pages=3363-3372&amp;pmid=24840811&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0053">53. <span class="mixed-citation">
Li B, Smith TJ. <span class="ref-title">Regulation of IL-1 receptor antagonist by TSH in fibrocytes and orbital fibroblasts</span>. <span class="ref-journal">J Clin Endocrinol Metab.</span> 2014;<span class="ref-vol">99</span>(4):E625-E633. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3973776/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24446657" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab.&amp;title=Regulation+of+IL-1+receptor+antagonist+by+TSH+in+fibrocytes+and+orbital+fibroblasts&amp;volume=99&amp;publication_year=2014&amp;pages=E625-E633&amp;pmid=24446657&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0054">54. <span class="mixed-citation">
Dottore GR, Bucci I, Lanzolla G, et al.. 
<span class="ref-title">Genetic profiling of orbital fibroblasts from patients with graves&#x02019; orbitopathy</span>. <span class="ref-journal">J Clin Endocrinol Metab.</span> 2021;<span class="ref-vol">106</span>(5):e2176-e2190. [<a href="https://pubmed.ncbi.nlm.nih.gov/33484567" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab.&amp;title=Genetic+profiling+of+orbital+fibroblasts+from+patients+with+graves&#x02019;+orbitopathy&amp;volume=106&amp;publication_year=2021&amp;pages=e2176-e2190&amp;pmid=33484567&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CIT0055">55. <span class="mixed-citation">
Pritchard J, Tsui S, Horst N, Cruikshank WW, Smith TJ. <span class="ref-title">Synovial fibroblasts from patients with rheumatoid arthritis, like fibroblasts from Graves&#x02019; disease, express high levels of IL-16 when treated with Igs against insulin-like growth factor-1 receptor</span>. <span class="ref-journal">J Immunol.</span> 2004;<span class="ref-vol">173</span>(5):3564-3569. [<a href="https://pubmed.ncbi.nlm.nih.gov/15322222" ref="reftype=pubmed&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol.&amp;title=Synovial+fibroblasts+from+patients+with+rheumatoid+arthritis,+like+fibroblasts+from+Graves&#x02019;+disease,+express+high+levels+of+IL-16+when+treated+with+Igs+against+insulin-like+growth+factor-1+receptor&amp;volume=173&amp;publication_year=2004&amp;pages=3564-3569&amp;pmid=15322222&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=9516078&amp;issue-id=418077&amp;journal-id=561&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">The Journal of Clinical Endocrinology and Metabolism</span> are provided here courtesy of <strong>The Endocrine Society</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="other_item"><a href="/pmc/articles/PMC9516078/?report=printable" class="sidefm-pmclink">Printer Friendly</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/9516078/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/9516078/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="9516078" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9516078%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="HzCe3FVMaZuQE1gdys2jTqkj7pzbhChNs1pyLnbH5mIHc44G6E7vZmxlGRXBtcIw">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9516078%2F&amp;text=Teprotumumab%20Divergently%20Alters%20Fibrocyte%20Gene%20Expression%3A%20Implications%20for%20Thyroid-associated%20Ophthalmopathy" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9516078%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516078/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC9516078/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/35809263/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC9516078/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/35809263/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC9516078/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/9516078/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC9516078/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
